About this trial
The objective of this study is to evaluate the performance and safety of the VCool Intranasal Cooling System in healthy adult volunteers. The study is designed to gather preliminary data regarding air flow rates and time required to reduce core body temperature to 35.5℃ and maintain the temperature between 35℃ and 36℃ for one hour after cooling.
Eligibility criteria
Qualifiers
Male or female ages 18 to 55.
An Institutional Review Board (IRB) approved informed consent is signed and dated prior to any study-related activities.
Baseline core body temperature between 36.8℃ and 37.5℃.
Have the ability to understand the requirements of the study and are willing to comply with all study procedures.
Disqualifiers
History of cardiovascular, respiratory, or metabolic disorder
Any contraindication to undergoing Magnetic Resonance Imaging (MRI)
Pregnant
Severe peripheral vascular disease
Trial design
Treatments tested in this trial
- Targeted Temperature Management Intranasal Cooling System
Treatment groups
Sponsors and collaborators
NeuroIntact Inc.
Lead sponsor
University of Maryland, Baltimore
Collaborator
United States Department of Defense
Collaborator